Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
1.8
-116.57%
Never
—
-86.06%
20%
—
5 Years
Score1.8
Net Growth-116.57%
Net TrendNever
Net Income Consistency—
Rev Growth-86.06%
Rev Trend20%
Revenue Consistency—
BioNTech SE fundamental performance
Across BioNTech SE's full reported history, from 2019 to 2025, revenue grew from € 108M to € 2.75B and net income went from -€ 179M to -€ 1.09B. Revenue increased in 43% of the years measured; net income in 29%.
BioNTech SE currently holds a 5-year HDB Score of 1.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 92.74 | — |
1 Year2025-08-12 | $ 111.00 | -16.45% |
5 Years2021-08-12 | $ 369.13 | -74.88% |
All Time2019-10-10 | $ 14.05 | 6x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-10-10 |
|---|---|---|---|---|
| Price | $ 92.74 | $ 111.00 | $ 369.13 | $ 14.05 |
| Return | — | -16.45% | -74.88% | 6x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | € 2.64B | -€ 1.70B | € 9.73B |
| 2025 | € 2.75B | -€ 1.09B | € 14.83B |
| 2024 | € 2.75B | -€ 665M | € 16.78B |
| 2023 | € 3.81B | € 930M | € 16.54B |
| 2022 | € 17.31B | € 9.43B | € 14.06B |
| 2021 | € 18.97B | € 10.29B | € 2.07B |
| 2020 | € 482M | € 15M | € 1.34B |
| IPO2019 | € 108M | -€ 179M | € 520M |
Explore beyond BNTX
You're looking at BioNTech SE. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
